Results 271 to 280 of about 207,835 (296)
Some of the next articles are maybe not open access.

Carrier Deformability in Drug Delivery

Current Pharmaceutical Design, 2016
Deformability is a key property of drug carriers used to increase the mass penetration across the skin without disrupting the lipid barrier. Highly deformable vesicles proved to be more effective than conventional liposomes in delivering drugs into and across the mammalian skin upon topical non occlusive application.
Morilla, María José   +1 more
openaire   +4 more sources

Liposome as a drug carrier

Asian Journal of Research in Pharmaceutical Science, 2019
One of various talented new drug delivery systems, liposomes characterize an advanced technology to deliver active molecules to the site of action, and at present, several formulations are in clinical use. The liposome consist of phospholipids, which have phosphoric acid sides to form the liposome players.
Manoj M. Nitalikar   +3 more
openaire   +2 more sources

Liposomes as Carriers of Antimicrobial Drugs

Drug Development and Industrial Pharmacy, 1997
Liposome are promising drug carrier systems being developed. Their successful use in the treatment of several diseases demonstrates that a solid rationale for clinical development of liposomes as antimicrobial drug carriers can be established. There are a number of potential drug candidates for liposome encapsulation.
Šiler-Marinković, Slavica   +3 more
openaire   +3 more sources

Microemulsions as carriers for drugs and nutraceuticals

Advances in Colloid and Interface Science, 2006
Microemulsions are potentially excellent carriers for bioactive molecules. They offer the advantage of spontaneous formation, ease of manufacture, thermodynamic stability, and improved solubilization of bioactive materials. This review explores some of the new trends in microemulsion research through analysis of some representative studies.
Aviram Spernath, Abraham Aserin
openaire   +2 more sources

Polymeric microspheres as drug carriers

Biomaterials, 1988
The use of polymeric microsphere systems (including polypeptides) as vehicles for delivering drugs by a variety of routes is considered with particular reference to parenteral administration. Microsphere formulation is discussed with emphasis on the role of surface properties and how these can determine the fate of administered particles.
Stanley S. Davis, Lisbeth Illum
openaire   +3 more sources

ChemInform Abstract: Cyclodextrin Drug Carrier Systems

ChemInform, 1998
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Fumitoshi Hirayama   +2 more
openaire   +4 more sources

Driving forces for drug loading in drug carriers

Journal of Microencapsulation, 2015
The loading capacity of a drug carrier is determined essentially by intermolecular interactions between drugs and carrier materials. In this review, the process of drug loading is described in detail based on the differences in the driving force for drug incorporation, including hydrophobic interaction, electrostatic interaction, hydrogen bonding, Pi ...
Yang Li, Li Yang
openaire   +3 more sources

Molecular Insights into the Effects of Media–Drug and Carrier–Drug Interactions on pH-Responsive Drug Carriers

Molecular Pharmaceutics, 2018
We have performed two sets of all atom molecular dynamics (MD) simulations of poly(acrylic acid) (PAA) oligomers, considered as a model pH-responsive drug carrier. In the first set, multiple oligomers of PAA are simulated in model gastric and intestinal fluids, where the degree of deprotonation of PAA oligomers is varied with the medium pH.
Ratna S. Katiyar, Prateek K. Jha
openaire   +3 more sources

Peptide vectors as drug carriers

2003
During the last decade, several peptides have been described, such as SynB vectors [1] penetratin and Tat [2, 3] that allow the intracellular delivery of polar, biologically active compounds in vitro and in vivo [2, 4]. These peptides, belonging to various families, are heterogeneous in size (10 to 18 amino acids) and sequence (Tab. 1).
Jean-Michel Scherrmann, Jamal Temsamani
openaire   +3 more sources

Site-Specific Drug Carriers

Engineering in Medicine, 1986
Site-specific drug carriers are required to exclusively deliver drug molecules to difficult targets within the body. They should do so in a form which protects the drug and host from one another. This contribution reviews the reasons for drug targeting, and describes some of the features required of two types of carrier system, i.e., particulates and ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy